Alexion Pharmaceuticals (ALXN)

Add to Watchlists
Create an Alert
149.80 +0.75  +0.50% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Alexion Pharmaceuticals Research and Development Expense (Quarterly):

85.78M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Alexion Pharmaceuticals Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Alexion Pharmaceuticals Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 85.78M
Sept. 30, 2013 88.21M
June 30, 2013 68.56M
March 31, 2013 74.54M
Dec. 31, 2012 63.41M
Sept. 30, 2012 54.28M
June 30, 2012 59.64M
March 31, 2012 45.41M
Dec. 31, 2011 34.40M
Sept. 30, 2011 36.57M
June 30, 2011 35.65M
March 31, 2011 30.81M
Dec. 31, 2010 27.18M
Sept. 30, 2010 25.15M
June 30, 2010 23.69M
March 31, 2010 22.37M
Dec. 31, 2009 23.22M
Sept. 30, 2009 21.32M
June 30, 2009 18.29M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Oct. 31, 2005 Upgrade
July 31, 2005 Upgrade
April 30, 2005 Upgrade
Jan. 31, 2005 Upgrade
Oct. 31, 2004 Upgrade
July 31, 2004 Upgrade
April 30, 2004 Upgrade
Jan. 31, 2004 Upgrade
Oct. 31, 2003 Upgrade
July 31, 2003 Upgrade
April 30, 2003 Upgrade
Jan. 31, 2003 Upgrade
Oct. 31, 2002 Upgrade
July 31, 2002 Upgrade
April 30, 2002 Upgrade
Jan. 31, 2002 Upgrade
Oct. 31, 2001 Upgrade
July 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

ALXN Research and Development Expense (Quarterly) Benchmarks

Companies
Amgen 1.249B
Regeneron Pharmaceuticals 268.14M
Gilead Sciences 551.98M

ALXN Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 18.29M Jun 2009
Maximum 88.21M Sep 2013
Average 44.13M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.